Journal
BRITISH JOURNAL OF PSYCHIATRY
Volume 191, Issue -, Pages S52-S57Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1192/bjp.191.50.s52
Keywords
-
Categories
Ask authors/readers for more resources
Background As understanding of the pathobiology of schizophrenia increases, the challenge is to relate such measures to outcome at a functional level. Aims To consider our current understanding of how neurobiological variables relate to functional outcome and might constitute outcome measures in their own right. Method Critical appraisal of recent evidence on structural and functional imaging, neurological evaluation, early neurodevelopmental indices, genomics, proteomics, metabolomics and apoptotic mechanisms in relation to outcome. Results Studies conducted prospectively from the first episode of schizophrenia are generating more reliable findings but currently lack predictive power. Prediction of transition from 'high-risk' status to first episode has proved somewhat more fruitful, but the gain has been modest and circumscribed. Conclusions Our current level of understanding does not yet allow the generation of predictive models on an individual patient basis. Genomic and metabolomic studies hold particular potential for generating clinically meaningful 'biomarkers' but considerable further work is necessary. Declaration of interest None. Funding detailed in Acknowledgements.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available